for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Petmed Express Inc

PETS.OQ

Latest Trade

32.28USD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

15.13

 - 

42.80

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
32.28
Open
--
Volume
--
3M AVG Volume
16.95
Today's High
--
Today's Low
--
52 Week High
42.80
52 Week Low
15.13
Shares Out (MIL)
20.27
Market Cap (MIL)
656.82
Forward P/E
21.39
Dividend (Yield %)
3.46

Next Event

Q2 2020 Petmed Express Inc Earnings Release

Latest Developments

More

Petmed Express Reports Q1 EPS $0.39

Petmed Express Announces Fourth Quarter And Fiscal Year End Financial Results

PetMed Express Posts Quarterly Earnings Per Share Of 34 Cents

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Petmed Express Inc

PetMed Express, Inc. (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies. Its products include brands of medication, such as Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Revolution and Rimadyl. It also offers additional pet supplies for sale on its Website, which are drop shipped to its customers by third parties. These pet supplies include food, beds, crates, stairs, strollers and other pet supplies. Its products included Non-Prescription Medications (Over the Counter (OTC)) and supplies, and Prescription Medications (Rx). Its customers are located in California, Florida, Texas, New York, Virginia and Georgia, among others.

Industry

Retail (Catalog & Mail Order)

Contact Info

420 S Congress Ave

DELRAY BEACH, FL

33445-4693

United States

+1.561.4264444

https://www.1800petmeds.com/

Executive Leadership

Robert C. Schweitzer

Independent Chairman of the Board

Menderes Akdag

President, Chief Executive Officer, Director

Bruce S. Rosenbloom

Chief Financial Officer, Treasurer

Leslie C.G. Campbell

Independent Director

Frank J. Formica

Independent Director

Key Stats

3.50 mean rating - 2 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

0.3K

2019

0.3K

2020

0.3K

2021(E)

0.3K
EPS (USD)

2018

1.820

2019

1.840

2020

1.290

2021(E)

1.515
Price To Earnings (TTM)
22.92
Price To Sales (TTM)
2.19
Price To Book (MRQ)
4.92
Price To Cash Flow (TTM)
21.52
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
21.91
Return on Equity (TTM)
18.39

Latest News

Latest News

BRIEF-Petmed Express Announces Fourth Quarter And Fiscal Year End Financial Results

* PETMED EXPRESS, INC. D/B/A 1-800-PETMEDS ANNOUNCES ITS FOURTH QUARTER AND FISCAL YEAR END FINANCIAL RESULTS AND INCREASES ITS QUARTERLY DIVIDEND TO $0.28 PER SHARE

IN BRIEF: Two men settle PetMed insider-trading case for $1.25 million

A Florida advertising executive and the president of a New York insurance company have agreed to pay nearly $1.25 million to resolve charges they traded on inside information concerning online pet pharmacy PetMed Express Inc's financial results.

PetMed signs up with major manufacturers, sees price war stabilizing

PetMed Express Inc <PETS.O> attributed the improvement in its quarterly profit margin to new supply contracts with manufacturers of animal drugs and said it expected the intense price war among online retailers of pet products to ease.

Shares of online pet store PetMed surge after profit beat

Shares of PetMed Express Inc rise 29% on Monday as the online pet medicine retailer beat Wall Street expectations for quarterly profit after three straight quarters of missing estimates.

BRIEF-PetMed Express Reports Q4 Earnings Per Share Of $0.50

* PETMED EXPRESS, INC. D/B/A 1-800-PETMEDS ANNOUNCES RECORD EARNINGS FOR ITS 4TH FISCAL QUARTER AND ITS QUARTERLY DIVIDEND OF $0.25 PER SHARE

BRIEF-‍Plaintiffs Dismiss Shareholders Claims Dated August And September 2017

* PETMED EXPRESS - PLAINTIFFS INVESTIGATED SHAREHOLDERS CLAIMS DATED AUGUST AND SEPT 2017, VOLUNTARILY DISMISSED CONSOLIDATED LAWSUIT - SEC FILING Source text for Eikon: [http://bit.ly/2Dyf1G6] Further company coverage:

BRIEF-PetMed Express Reports Q3 EPS OF $0.44

* PETMED EXPRESS D/B/A 1-800-PETMEDS ANNOUNCES ITS THIRD QUARTER FINANCIAL RESULTS AND INCREASED ITS QUARTERLY DIVIDEND BY 25% TO $0.25 PER SHARE

BRIEF-Petmed Express Q2 earnings per share $0.43

* Petmed Express D/B/A 1-800-petmeds announces record second quarter financial results

PetMed CFO says allegations of marketing to opioid addicts are 'bogus'

A short seller's allegations that PetMed Express markets pet medicine to human opioid addicts are "bogus," PetMed Chief Financial Officer Bruce Rosenbloom told Reuters on Wednesday.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up